Evidence map›Paper›PMID 33014989›Full record

ArticleFrontiers in bioengineering and biotechnology2020

Investigation of Cancer Cell Migration and Proliferation on Synthetic Extracellular Matrix Peptide Hydrogels.

Zbigniev Balion, Emilija Sipailaite, Gabija Stasyte, Agne Vailionyte, Airina Mazetyte-Godiene, Ieva Seskeviciute, Rasa Bernotiene, Jaywant Phopase, Aiste Jekabsone

Open access · goldAbstract read
In one paragraph

Article in Frontiers in bioengineering and biotechnology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Multiple Cell Cultures for MRI Analysis.International journal of molecular sciences · 2022
    Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. 3D Reconstitution of the Neural Stem Cell Niche: Connecting the Dots.Frontiers in bioengineering and biotechnology · 2021
    Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Zbigniev BalionInstitute of Pharmaceutical Technologies, Lithuanian University of Health Sciences, Kaunas, Lithuania.
Emilija SipailaiteInstitute of Pharmaceutical Technologies, Lithuanian University of Health Sciences, Kaunas, Lithuania.
Gabija StasyteInstitute of Pharmaceutical Technologies, Lithuanian University of Health Sciences, Kaunas, Lithuania.
Agne VailionyteFerentis UAB, Vilnius, Lithuania.
Airina Mazetyte-GodieneFerentis UAB, Vilnius, Lithuania.
Ieva SeskeviciuteInstitute of Pharmaceutical Technologies, Lithuanian University of Health Sciences, Kaunas, Lithuania.
Rasa BernotieneLaboratory of Molecular Neurobiology, Neuroscience Institute, Lithuanian University of Health Sciences, Kaunas, Lithuania.
Jaywant PhopaseDepartment of Physics, Chemistry and Biology, Linköping University, Linköping, Sweden.
Aiste JekabsoneInstitute of Pharmaceutical Technologies, Lithuanian University of Health Sciences, Kaunas, Lithuania.
Lithuanian University of Health Sciences · LTCenter for Physical Sciences and Technology · LTLinköping University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chemical and mechanical properties of a tumor microenvironment are essential players in cancer progression, and it is important to precisely control the extracellular conditions while designing cancer

Indexed as

cell adhesion peptidescollagen like peptidefocal adhesionglioblastomamelanomamigrationproliferation

Identifiers

PMID33014989
PMCPMC7498748
OpenAlexW3083488836

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.